TScan Therapeutics
TCRX
#9270
Rank
S$95.15 M
Marketcap
$1.68
Share price
-1.19%
Change (1 day)
-83.02%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$3.93

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.90. In 2022 the company made an earnings per share (EPS) of -$3.71 a decrease over its 2021 EPS that were of -$2.94.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.935.85%
2022-$3.7126.25%
2021-$2.9499.58%
2020-$1.47